TY - JOUR T1 - COVALENT BINDING OF 2-PHENYLPROPIONYL-<em>S</em>-ACYL-COA THIOESTER TO TISSUE PROTEINS IN VITRO JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 727 LP - 730 DO - 10.1124/dmd.31.6.727 VL - 31 IS - 6 AU - Chunze Li AU - Mobolaji O. Olurinde AU - Laura M. Hodges AU - Mark P. Grillo AU - Leslie Z. Benet Y1 - 2003/06/01 UR - http://dmd.aspetjournals.org/content/31/6/727.abstract N2 - In this study, we investigated the possible involvement of acyl-CoA, reactive intermediary metabolites of 2-arylpropionic acids (profens), in protein adduct formation in rat liver homogenate and in human serum albumin (HSA) in buffer. (RS)-[1-14C]-2-Phenylpropionic acid (14C-2-PPA, 1 mM) was incubated with rat liver homogenate (1.5 mg/ml) in the presence of cofactors of acyl-CoA formation (Mg2+, ATP, and CoA). Aliquots of the incubation mixture were analyzed for covalent binding and acyl-CoA formation over a 3-h period. High-performance liquid chromatographic analysis of the products from such incubations showed the presence of 2-phenylpropionyl-S-acyl-CoA (2-PPA-CoA), which was confirmed by coelution with authentic 2-PPA-CoA, as well as by mass spectrometry. In the same incubations, 2-PPA was shown to bind covalently to hepatic proteins in a time- and ATP-dependent fashion. Inhibition of 2-PPA-CoA formation by acyl-CoA synthetase inhibitors, such as palmitic acid, lauric acid, octanoic acid, and ibuprofen, markedly decreased the extent of covalent binding of 2-PPA to hepatic proteins. Results from these in vitro studies strongly suggest that acyl-CoA thioester derivatives are chemically reactive and are able to bind covalently to tissue proteins in vitro, and, therefore, may contribute significantly to covalent adduct formation of profen drugs in vivo. The American Society for Pharmacology and Experimental Therapeutics ER -